Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04108442 · ClinicalTrials.gov registry record · NA
Patient Satisfaction With Virtual Postoperative Visit
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT04108442: Completed NA study, sponsored by NYU Langone Health.
NCT04108442 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04108442, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. To reduce bias that may occur due to each surgeon's personal preference for postoperative follow-up modality, the surgeons (rather than individual subjects) will be randomized to one of two postoperative follow-up modality groups (traditional or virtual).
Primary Outcome
Patients will report their satisfaction with their surgical experience 6 weeks after surgery using a 10-point Likert scale, 0-"Completely Dissatisfied, 10-"Completely Satisfied"
Interventions
- BEHAVIORAL Traditional
- BEHAVIORAL Virtual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
What the finished NCT04108442 record still lists
NCT04108442 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Traditional is the first listed.
NCT04108442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04108442 about?
NCT04108442 is a clinical study titled "Patient Satisfaction With Virtual Postoperative Visit". This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. To reduce bias that may occur due to each surgeon's personal pref...
What is the current status of trial NCT04108442?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2019-08-01. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04108442?
The interventions under investigation include: Traditional (BEHAVIORAL), Virtual (BEHAVIORAL).
Who is sponsoring clinical trial NCT04108442?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04108442's enrollment target sits among peer trials
122 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI